Cigna Corp Net Income Over Time
| CI Stock | USD 291.45 0.00 0.00% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Cigna Corp Performance and Cigna Corp Correlation. Is there potential for Health Care Providers & Services market expansion? Will Cigna introduce new products? Factors like these will boost the valuation of Cigna Corp. Projected growth potential of Cigna fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Cigna Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.11) | Dividend Share 6.04 | Earnings Share 22.18 | Revenue Per Share | Quarterly Revenue Growth 0.104 |
Cigna Corp's market price often diverges from its book value, the accounting figure shown on Cigna's balance sheet. Smart investors calculate Cigna Corp's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Cigna Corp's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Cigna Corp's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cigna Corp should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Cigna Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Income Analysis
Compare Cigna Corp and related stocks such as Elevance Health, Cencora, and Regeneron Pharmaceuticals Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ELV | 172.4 M | 2.6 B | 2.7 B | 2.7 B | 2.6 B | 2.6 B | 2.5 B | 3.8 B | 3.8 B | 4.8 B | 4.6 B | 6.1 B | 5.9 B | 6 B | 6 B | 5.7 B | 3.3 B |
| COR | (207.7 M) | 719 M | 433.7 M | 276.5 M | (134.9 M) | 1.4 B | 414.5 M | 1.7 B | 855.4 M | (3.4 B) | 1.5 B | 1.7 B | 1.7 B | 1.5 B | 1.6 B | 1.8 B | 1.9 B |
| REGN | (3.3 M) | (221.8 M) | 750.3 M | 424.4 M | 348.1 M | 636.1 M | 895.5 M | 1.2 B | 2.4 B | 2.1 B | 3.5 B | 8.1 B | 4.3 B | 4 B | 4.4 B | 4.5 B | 4.7 B |
| ZTS | (100 M) | 245 M | 436 M | 504 M | 583 M | 339 M | 821 M | 864 M | 1.4 B | 1.5 B | 1.6 B | 2 B | 2.1 B | 2.3 B | 2.5 B | 2.7 B | 2.8 B |
| IDXX | 3.2 M | 161.8 M | 178.3 M | 187.8 M | 181.9 M | 192.1 M | 222 M | 263.1 M | 377 M | 427.7 M | 581.8 M | 744.8 M | 679.1 M | 845 M | 887.9 M | 1.1 B | 1.1 B |
| CVS | 210.2 M | 3.5 B | 3.9 B | 4.6 B | 4.6 B | 5.2 B | 5.3 B | 6.6 B | (594 M) | 6.6 B | 7.2 B | 8 B | 4.3 B | 8.3 B | 4.6 B | 1.8 B | 2.6 B |
| CNC | (9.4 M) | 111.2 M | 2 M | 165.1 M | 271 M | 355 M | 562 M | 828 M | 900 M | 1.3 B | 1.8 B | 1.3 B | 1.2 B | 2.7 B | 3.3 B | (6.7 B) | (6.3 B) |
| BDX | 88 M | 1.2 B | 1.3 B | 1.2 B | 695 M | 976 M | 1.1 B | 311 M | 1.2 B | 874 M | 2.1 B | 1.8 B | 1.5 B | 1.7 B | 1.7 B | 1.9 B | 2 B |
| CAH | 6 M | 1.1 B | 334 M | 1.2 B | 1.2 B | 1.4 B | 1.3 B | 256 M | 1.4 B | (3.7 B) | 611 M | (938 M) | 330 M | 852 M | 1.6 B | 1.8 B | 1.9 B |
Cigna Corp and related stocks such as Elevance Health, Cencora, and Regeneron Pharmaceuticals Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Cigna Corp financial statement analysis. It represents the amount of money remaining after all of Cigna Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Cigna Corp | CI |
| Classification | Healthcare |
| Business Address | 900 Cottage Grove |
| Exchange | New York Stock Exchange |
USD 291.45
Check out Cigna Corp Performance and Cigna Corp Correlation. For more detail on how to invest in Cigna Stock please use our How to Invest in Cigna Corp guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Cigna Corp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.